Internal Medicine, Laboratory Diagnostics, Endocrinology and Metabolism

Dr Michael Pedrini, MD and Assoc. Professor (Ao. Univ.-Prof)

Specialist in Internal Medicine, Medical and Chemical Laboratory Diagnostics, Specialist in Endocrinology and Metabolism

Dr Michael Pedrini completed his professional training at the Innsbruck University Hospital and Harvard Medical School in Boston, USA. From 1999 to 2016, he worked as a specialist at Innsbruck Hospital while contributing to various research projects focused on diseases of affluence, particularly diabetes mellitus. His work in this field has resulted in the publication of numerous studies. Since 2016, he has headed the Department of Internal Medicine at Brixsana, where he also works as a laboratory specialist.

Obesity
Diabetes (diabetes mellitus)
High blood pressure (arterial hypertension)
Elevated blood lipids (hyperlipidaemia)
Vascular calcification (arteriosclerosis)
2016-present

Head of Internal Medicine and Head of Laboratory, Brixsana

2006–2016

Senior Physician Special Ward 4A (General Internal Medicine Ward) and Senior Physician at the Metabolic Outpatient Clinic of the Department of Internal Medicine I, Innsbruck

2005–2006

Senior Physician, Metabolic Ward of the Department of Internal Medicine I, Innsbruck

2004–2005

Senior Physician, Emergency Department and Emergency Ward of the Department of Internal Medicine I, Innsbruck

2002–2004

Senior Physician, General Outpatient Clinic of the Department of Internal Medicine I, Innsbruck

1999–2002

Senior Physician, Metabolic Ward and Metabolic Outpatient Clinic, Innsbruck

1990–1994

Fellowship at the Joslin Diabetes Center, Brigham Women’s Hospital and Harvard Medical School, Boston, USA

1986

Exchange Programme Columbia University, New York, USA

The Effect of Dietary Protein Restriction on the Progression of Diabetic and Nondiabetic Renal Diseases: A Meta-Analysis. Ann. Intern. Med.
Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels. Diabetologia (2005) 48: 756-766
Postprandial lipemia induces an acute decrease of insulin sensitivity in healthy men independently of plasma NEFA levels. Diabetologia
Postprandial lipemia induces pancreatic α cell dysfunction characteristic of type 2 diabetes: studies in healthy subjects, mouse pancreatic islets and cultured pancreatic α cells. Am J Clin Nutr.
Dr Michael Pedrini, MD and Assoc. Professor (Ao. Univ.-Prof)

Book your appointment now

You’re in good hands – even when scheduling your appointment. It’s quick, straightforward and hassle-free.

Medical services

Comprehensive expertise for your health. Broad-ranging yet highly specialised. Our departments.

About us

People-centred, cutting-edge healthcare for South Tyrol. Prompt, competent, personal. .